FDG/PET in CLL today.
In this issue of Blood, Falchi et al present their experience with 2-deoxy-2-[18F] fluoroglucose/positron emission tomography (FDG/PET) in the management of patients with chronic lymphocytic leukemia (CLL) or Richter syndrome (RS) over a 10-year period at a referral center. The results of this study shed light on the potential role of FDG/PET in CLL.
AZIENDA OSPEDALIERA "PUGLIESE-CIACCIO"
Stefano
S
Molica
D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000401:mortality*; D008297:Male; D049268:Positron-Emission Tomography
D019788:Fluorodeoxyglucose F18